A Maturing Market
Investment management and mutual funds are showing more interest in the genomics industry, according to a recent report, diminishing some companies’ reliance on venture capital and indicating a shift to mainstream. Shown here: top genomics investors, by total share price value (in millions)
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
